Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates in two segments, Proteomics and Genomics. Its proteomics and genomics include instruments, consumables, software,...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers.
Target Price
The average target price of LAB is 1.6 and suggests 67% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell